Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: June 21, 2018

DrugPatentWatch Database Preview

Amneal Pharms Co Company Profile

« Back to Dashboard

What is the competitive landscape for AMNEAL PHARMS CO, and what generic and branded alternatives to AMNEAL PHARMS CO drugs are available?

AMNEAL PHARMS CO has thirty-six approved drugs.

There are two tentative approvals on AMNEAL PHARMS CO drugs.

Summary for Amneal Pharms Co

US Patents:	0
Tradenames:	34
Ingredients:	34
NDAs:	36

Drugs and US Patents for Amneal Pharms Co

+ Get email alerts for changes to this table

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Amneal Pharms Co	ARGATROBAN	argatroban	INJECTABLE;INJECTION	206698-001	Jan 26, 2018	AP	RX	No	No		➤ Sign Up				➤ Sign Up
Amneal Pharms Co	BUSPIRONE HYDROCHLORIDE	buspirone hydrochloride	TABLET;ORAL	208829-003	May 24, 2017	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Amneal Pharms Co	ELETRIPTAN HYDROBROMIDE	eletriptan hydrobromide	TABLET;ORAL	206787-002	May 25, 2018	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Amneal Pharms Co	BUSULFAN	busulfan	INJECTABLE;INJECTION	209580-001	Dec 18, 2017	AP	RX	No	No		➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Paragraph IV (Patent) Challenges for AMNEAL PHARMS CO drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Injection	100 mg/mL, 2.5 mL vials	➤ Subscribe	2007-09-24
➤ Subscribe	Injection	1 mg/mL, 50 mL vials	➤ Subscribe	2011-12-16

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture

Cipla

Express Scripts

Daiichi Sankyo

Dow

Mallinckrodt

UBS

Julphar

Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.